MedPath

Co-stimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from cholangiocarcinoma

Recruiting
Conditions
bile duct cancer
cholangiocarcinoma
10019815
Registration Number
NL-OMON43309
Lead Sponsor
Stichting Leveronderzoek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
102
Inclusion Criteria

Adult cholangiocarcinoma (CCA) patients that will undergo surgery for this disease.

Exclusion Criteria

Patients who refuse blood donation/participation in the study
Patients with a severe immunocompromised condition, or patients taking immunosuppressive medication

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath